Aiwen Wu

机构：Peking University, Peking University Cancer Hospital, Central People's Hospital of Zhanjiang, Monash Health, Ministry of Education · ORCID：0000-0003-1877-7005

发表论文 167 篇 · 总被引 3895 次 · h-index 33

代表论文

• Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial (2025 · The Lancet Oncology · 被引 56)
• Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial (2024 · Journal of Clinical Oncology · 被引 48)
• Laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): 3-year survival outcomes of a multicentre, randomised, controlled, non-inferiority trial (2024 · ˜The œLancet. Gastroenterology & hepatology · 被引 24)
• Circulating tumour DNA in predicting and monitoring survival of patients with locally advanced rectal cancer undergoing multimodal treatment: long-term results from a prospective multicenter study (2025 · EBioMedicine · 被引 16)
• Neoadjuvant Immunotherapy Alone for Patients With Locally Advanced and Resectable Metastatic Colorectal Cancer of dMMR/MSI-H Status (2024 · Diseases of the Colon & Rectum · 被引 16)
• A new treatment strategy for mid-low rectal cancer patients exhibiting a clinical complete or near-complete response to neoadjuvant chemoradiotherapy: Transanal endoscopic microsurgery ——A multicenter prospective case-control clinical trial by MONT-R (2024 · European Journal of Cancer · 被引 7)